All Stories

  1. Study of bone metabolism and angiogenesis in patients undergoing high-dose chemotherapy/autologous hematopoietic stem cell transplantation

    Article • European Journal Of Haematology, December 2017, Wiley

    Dr Marie-Christine Kyrtsonis, Dr Maria K Angelopoulou

  2. Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies

    Article • European Journal Of Haematology, September 2017, Wiley

    Dr Marie-Christine Kyrtsonis, Dr Eleftheria Hatzimichael

  3. Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience

    Article • Hematological Oncology, February 2017, Wiley

    Dr Marie-Christine Kyrtsonis, Dr Maria K Angelopoulou, Dimitrios Grenzelias, Vasiliki Pappa, Dr Eleftheria Hatzimichael

  4. Has the time come to reevaluate prognostic factors and to rebuild staging systems for Multiple Myeloma?

    Article • European Journal Of Haematology, February 2015, Wiley

    Dr Marie-Christine Kyrtsonis

  5. Aggressive relapses in multiple myeloma revealed by free light chain or total paraprotein escape

    Article • Current Angiogenesis, February 2014, Bentham Science Publishers

    Dr Marie-Christine Kyrtsonis

  6. Genetic and molecular mechanisms in multiple myeloma: a route to better understand disease pathogenesis and heterogeneity

    Article • The Application of Clinical Genetics, July 2010, Taylor & Francis

    Dr Marie-Christine Kyrtsonis